"Inflammation Mediators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The endogenous compounds that mediate inflammation (AUTACOIDS) and related exogenous compounds including the synthetic prostaglandins (PROSTAGLANDINS, SYNTHETIC).
| Descriptor ID |
D018836
|
| MeSH Number(s) |
D23.469
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammation Mediators".
Below are MeSH descriptors whose meaning is more specific than "Inflammation Mediators".
This graph shows the total number of publications written about "Inflammation Mediators" by people in this website by year, and whether "Inflammation Mediators" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 4 | 5 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 3 | 0 | 3 |
| 2006 | 3 | 1 | 4 |
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 2 | 3 |
| 2009 | 4 | 5 | 9 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 2 | 4 |
| 2012 | 4 | 4 | 8 |
| 2013 | 1 | 1 | 2 |
| 2014 | 6 | 5 | 11 |
| 2015 | 5 | 4 | 9 |
| 2016 | 3 | 7 | 10 |
| 2017 | 2 | 7 | 9 |
| 2018 | 2 | 2 | 4 |
| 2019 | 2 | 2 | 4 |
| 2020 | 5 | 2 | 7 |
| 2021 | 2 | 5 | 7 |
| 2022 | 1 | 1 | 2 |
| 2024 | 0 | 1 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Inflammation Mediators" by people in Profiles.
-
Kolawole OR, Kashfi K. Reprogramming inflammation: Mechanisms and therapeutic targeting of eicosanoids and pro-resolving mediators. Eur J Pharmacol. 2025 Sep 15; 1003:177924.
-
Brai BIC, Joseph RO, Komolafe TR, Amosun BE, Crown OO, Komolafe K, Ogungbe IV. Neem seed oil ameliorates diabetic phenotype by suppressing redox imbalance, dyslipidaemia and pro-inflammatory mediators in a rodent model of type 2 diabetes. Arch Physiol Biochem. 2025 Jun; 131(3):351-365.
-
Singh SK, Singh R. Cytokines and Chemokines in Cancer Cachexia and Its Long-Term Impact on COVID-19. Cells. 2022 02 08; 11(3).
-
Al Omran AJ, Shao AS, Watanabe S, Zhang Z, Zhang J, Xue C, Watanabe J, Davies DL, Shao XM, Liang J. Social isolation induces neuroinflammation and microglia overactivation, while dihydromyricetin prevents and improves them. J Neuroinflammation. 2022 Jan 04; 19(1):2.
-
Baumer Y, McCurdy SG, Boisvert WA. Formation and Cellular Impact of Cholesterol Crystals in Health and Disease. Adv Biol (Weinh). 2021 11; 5(11):e2100638.
-
Kong N, Chen G, Wang H, Li J, Yin S, Cao X, Wang T, Li X, Li Y, Zhang H, Yu S, Tang J, Sood A, Zheng Y, Leng S. Blood leukocyte count as a systemic inflammatory biomarker associated with a more rapid spirometric decline in a large cohort of iron and steel industry workers. Respir Res. 2021 Sep 26; 22(1):254.
-
Reynolds D, Vazquez Guillamet C, Day A, Borcherding N, Vazquez Guillamet R, Chore?o-Parra JA, House SL, O'Halloran JA, Z??iga J, Ellebedy AH, Byers DE, Mudd PA. Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19. J Immunol. 2021 09 01; 207(5):1229-1238.
-
Rubas NC, Maunakea A. Medical School Hotline: Immunoepigenetic-Microbiome Axis: Implications for Health Disparities Research in Native Hawaiians and Pacific Islanders. Hawaii J Health Soc Welf. 2021 08; 80(8):195-198.
-
Pappolla MA, Perry G, Fang X, Zagorski M, Sambamurti K, Poeggeler B. Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer's disease. Neurobiol Dis. 2021 08; 156:105403.
-
Mahmoud M, Mayer M, Cancel LM, Bartosch AM, Mathews R, Tarbell JM. The glycocalyx core protein Glypican 1 protects vessel wall endothelial cells from stiffness-mediated dysfunction and disease. Cardiovasc Res. 2021 05 25; 117(6):1592-1605.